Survival Outcome of Rhabdomyosarcoma in Pediatric Patients Treated at the National Cancer Institute
Hanaa Rashad Mahmoud;
Abstract
Summary
R
habdomyosarcoma (RMS) is a rare mesenchymal malignancy that typically affects children and adolescents. RMS accounts for approximately 3% to 7% of all malignancies in children and adolescents, with an incidence of approximately 4.4–4.5 cases per
R
habdomyosarcoma (RMS) is a rare mesenchymal malignancy that typically affects children and adolescents. RMS accounts for approximately 3% to 7% of all malignancies in children and adolescents, with an incidence of approximately 4.4–4.5 cases per
Other data
| Title | Survival Outcome of Rhabdomyosarcoma in Pediatric Patients Treated at the National Cancer Institute | Other Titles | معدلات البقاء ونسبة الشفاء فى الأطفال المصابين بأورام العضلات (رابدوميوسركوما) بالمعهد القومى للأورام | Authors | Hanaa Rashad Mahmoud | Keywords | Survival Outcome of Rhabdomyosarcoma in Pediatric Patients Treated at the National Cancer Institute | Issue Date | 2013 | Description | Summary R habdomyosarcoma (RMS) is a rare mesenchymal malignancy that typically affects children and adolescents. RMS accounts for approximately 3% to 7% of all malignancies in children and adolescents, with an incidence of approximately 4.4–4.5 cases per |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.